Johnson & Johnson MedTech, a global leader in cardiac arrhythmia treatment, today announced European CE mark approval of the Dual Energy THERMOCOOL SMARTTOUCH™ SF Catheter for the treatment of cardiac ...

Johnson & Johnson MedTech (NYSE: JNJ) announced that it received CE mark approval for its dual-energy ThermoCool SmartTouch ...

Johnson & Johnson stock (NYSE: JNJ) lost about 7% in 2024, underperforming the broader S&P 500 index, which gained 23% for ...

The temporary pause follows reports of four cases of neurovascular events in the US external evaluation study.

Deutsche Bank upgraded Boston Scientific (BSX) to Buy from Hold with a price target of $108, up from $87. Boston Scientific’s :story has become ...

Mendaera announced today that it appointed surgical robotics veteran Eric Davidson as its first chief commercial officer (CCO ...

India's medical device industry, valued at US$12 billion, has become a growing hub for innovation, attracting venture capital ...

Just 61% of hospitals surveyed evaluated models for accuracy on their own data, and less than half evaluated the models for ...

Johnson & Johnson halted the limited rollout of its Varipulse pulsed field ablation system on Jan. 5 to “investigate the root causes of four reported neurovascular events in the U.S. external ...

FDA grants priority review tag to JNJ's nipocalimab BLA for gMG and asks for new warnings on GSK & PFE's RSV vaccine labels.

The PD-1 receptor, a major immune checkpoint inhibitor whose signaling is the target of multiple blockbuster anticancer drugs, differs functionally between rodents and humans in previously unknown ...

Med Tech & Diagnostics Analysts Matson and Saxon, along with Dr. Kevin Cronin, Assistant Professor of Orthopaedic Surgery at the University ...